Continued here:
Qualigen Therapeutics Presents Three Posters of QN-302 at American Association of Cancer Research Conference
Author Archives: Fredricko
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering
CORRECTION: Tower One Construction Update -Nine Towers Completed – Additional Non -Cancellable Rent of $2,300,000
Sanofi – AGM 03.05.2022 – Availability of Preparatory Documents
Read more from the original source:
Sanofi - AGM 03.05.2022 - Availability of Preparatory Documents
Interim Data from the Phase 1/1b AURELIO-03 Trial of SOT101 Presented at the AACR 2022 Annual Meeting
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Go here to see the original:
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Erasca Presents Compelling Preclinical Data Supporting Clinical Development of Potentially Best-In-Class Programs ERAS-007, ERAS-601, and ERAS-3490 at…
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting
PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on…
Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine Design and Delivery
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Pembrolizumab in Patients with…
Turning Point Therapeutics Announces Positive Topline Data by Blinded Independent Central Review for Repotrectinib Across All ROS1-Positive NSCLC…
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Strengthens Board of Directors with Appointment of Highly…
MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute…
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
See the original post here:
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering